Now showing items 1-1 of 1

    • Metabolic vulnerability in HER2-positive Breast Cancer 

      Ding, Yi (2018)
      The human epidermal growth factor receptor 2, or HER2, is overexpressed in 20-30% breast cancer patients and is associated with aggressive disease. Therapies targeting HER2, including monoclonal antibodies (trastuzumab and ...